 Effects diltiazem complications restenosis coronary angioplasty randomized placebo-controlled double-blinded trial usefulness empiric therapy calcium antagonist patients coronary angioplasty total patients high-dose diltiazem mean dose mg/day Treatment hours angioplasty Restenosis percent area stenosis quantitative angiographic techniques year angioplasty patients aspirin dipyridamole angioplasty Heparin verapamil procedure groups similar respect age extent coronary artery disease history lipid levels Procedural complications death Q-wave infarction acute occlusion focal spasm different diltiazem placebo patients Freedom acute complications patients groups One-year angiographic follow-up patients Restenosis rates similar diltiazem group placebo group incidence late cardiac events death Q-wave myocardial infarction recurrent angina coronary bypass graft surgery similar groups diltiazem overall restenosis rate prevent late events coronary angioplasty